(TARS) Tarsus Pharmaceuticals - Performance 41.8% in 12m
TARS performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
44.25%
#19 in Peer-Group
Rel. Strength
84.10%
#1210 in Stock-Universe
Total Return 12m
41.78%
#24 in Peer-Group
Total Return 5y
98.69%
#17 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 56.94 USD |
| 52 Week Low | 21.54 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 9.89 |
| Buy/Sell Signal +-5 | -0.43 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: TARS (41.8%) vs XLV (-5.1%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-4.5% | 145% | 360% | 61.3 | 55.3 | 0.61 | 23.7% | -5.15% |
| LLY NYSE Eli Lilly |
12% | -6.78% | 514% | 66.1 | 37 | 1.24 | 58.2% | 18.9% |
| NVS NYSE Novartis |
10.1% | 17.9% | 81.6% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| NOVN SW Novartis |
7.55% | 7.58% | 54.8% | 18.7 | 14.1 | 1.38 | 9.80% | 11.2% |
| SFZN SW Siegfried Holding |
-0.63% | 2.28% | 140% | 26.1 | 25 | 1.48 | 77.8% | 77.6% |
| GSK NYSE GlaxoSmithKline |
10% | 4.92% | 57.7% | 19.9 | 9.2 | 0.4 | -25.2% | 3.11% |
| AZN NASDAQ AstraZeneca |
9.51% | -4.27% | 58.6% | 28.9 | 15.9 | 0.96 | 52.7% | 22.3% |
| IPN PA Ipsen |
2.14% | -13% | 54.2% | 24.4 | 10.3 | 0.74 | -6.40% | -6.33% |
Performance Comparison: TARS vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for TARS
| Total Return (including Dividends) | TARS | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -6.00% | 4.35% | 1.11% |
| 3 Months | -13.90% | -6.89% | 5.58% |
| 12 Months | 41.78% | -5.08% | 10.51% |
| 5 Years | 98.69% | 50.53% | 109.12% |
| Trend Score (consistency of price movement) | TARS | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -51.6% | 65.8% | 69.9% |
| 3 Months | -78% | -72% | 69.3% |
| 12 Months | 64% | -62.2% | 43.2% |
| 5 Years | 27.9% | 88.5% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #153 | -9.92% | -7.03% |
| 3 Month | #141 | -7.53% | -18.45% |
| 12 Month | #23 | 49.37% | 28.30% |
| 5 Years | #15 | 46.82% | 8.37% |
FAQs
Does Tarsus Pharmaceuticals (TARS) outperform the market?
Yes,
over the last 12 months TARS made 41.78%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.08%.
Over the last 3 months TARS made -13.90%, while XLV made -6.89%.
Performance Comparison TARS vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
TARS vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -4.7% | -7.1% | -20% | 31% |
| US NASDAQ 100 | QQQ | -4.5% | -7.5% | -19.2% | 32% |
| German DAX 40 | DAX | -2.5% | -5.3% | -36.3% | 12% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -4.4% | -5.1% | -21.8% | 30% |
| Hongkong Hang Seng | HSI | -5.2% | -11.1% | -39% | 14% |
| India NIFTY 50 | INDA | -3% | -4.7% | -18.9% | 43% |
| Brasil Bovespa | EWZ | -7% | -6.5% | -40.2% | 33% |
TARS vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -4.4% | -7.5% | -22.8% | 19% |
| Consumer Discretionary | XLY | -4.2% | -4.2% | -10.1% | 24% |
| Consumer Staples | XLP | -4.4% | -5.8% | -21.4% | 35% |
| Energy | XLE | -10.6% | -8.9% | -23.6% | 39% |
| Financial | XLF | -3.1% | -3.4% | -22.8% | 18% |
| Health Care | XLV | -6.6% | -10.4% | -19.5% | 47% |
| Industrial | XLI | -3.7% | -6.3% | -25.5% | 24% |
| Materials | XLB | -4% | -7.4% | -20.7% | 42% |
| Real Estate | XLRE | -5.2% | -7% | -21% | 29% |
| Technology | XLK | -5% | -8% | -20.4% | 38% |
| Utilities | XLU | -6.1% | -6.5% | -28.3% | 20% |
| Aerospace & Defense | XAR | -3.7% | -11.8% | -36.9% | -1% |
| Biotech | XBI | -4.4% | -13.8% | -9.2% | 49% |
| Homebuilder | XHB | -3.1% | -1% | -4.5% | 51% |
| Retail | XRT | -0.8% | -5.8% | -12% | 41% |
TARS vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -16.5% | -24.7% | -29.8% | 39% |
| Natural Gas | UNG | -3.9% | -3.4% | -38.2% | 56% |
| Gold | GLD | -8.3% | -12.2% | -50.1% | -6% |
| Silver | SLV | -3.9% | -17.4% | -39.6% | 19% |
| Copper | CPER | -2.2% | -7.7% | -34.8% | 33% |
TARS vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -6.2% | -6.7% | -18.5% | 46% |
| iShares High Yield Corp. Bond | HYG | -5.2% | -6.5% | -23.6% | 33% |